2 ms·
There is another alternative: 3. Develop deep expertise in regulatory approval and manufacture. There is where essentially all of big biotech. You then in-sou
by s1artibartfast 6y ago
There is another alternative:
3. Develop deep expertise in regulatory approval and manufacture.
There is where essentially all of big biotech. You then in-source products from firms who cant scale or tolerate the risk. These firms operate at a scale where they don't need external investment. Regulatory capture is the more cynical description of this mode.